[Sentinel node detection of patients with breast cancer by radionuclide method: consideration of radiation safety].
Sentinel node was detected by 99mTc labeled nanocolloid in five patients with breast cancer. Surgery of breast cancer was done at 16 hours after the administration of 74 MBq of 99mTc labeled nanocolloid. Sentinel node was searched by scintigraphy prior to surgery and by gamma-probe during surgery. Radioactivity of injected site, sentinel nodes, blood contaminated gauze, and other garbage was measured by GM detector. Radiation to medical staffs was monitored by a pocket radiation detector and film batches. Sentinel nodes were successfully detected both by scintigraphy and gamma-detector. More than 70% of radioactivity remained in the administered site at 16 hours. Small amount of radioactivity was detectable in the sentinel node. Almost no radioactivity was detectable in blood-contaminated gauze and other garbage. Radiation dose to the main surgeon was 4 to 6 microSv per surgery by a pocket radiation detector. Radiation dose to the assistant surgeon was 2 microSv per surgery. Radiation dose by labeling or injection was 0 to 1 microSv per procedure. No detectable radiation was measured by film batches. It is concluded that the detection of sentinel node by 99mTc labeled nanocolloid is a safe procedure from the point of radiation safety consideration.
Koizumi
M
M
Department of Nuclear Medicine, Cancer Institute Hospital.
Nomura
E
E
Yamada
Y
Y
Takiguchi
T
T
Takahashi
K
K
Tada
T
T
Saito
M
M
Uchida
K
K
Makita
M
M
Yoshimoto
M
M
Kasumi
F
F
Takahashi
T
T
Sekine
N
N
Ogata
E
E
D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D003102:Colloids; D006801:Humans; D008503:Medical Staff; D009726:Nurses; D011829:Radiation Dosage; D011874:Radiometry; D011877:Radionuclide Imaging; D021701:Sentinel Lymph Node Biopsy / Q000379:methods*; D013667:Technetium
D003102:Colloids; D013667:Technetium